DocMorris AG (ZRSEF)
USD 39.03
(0.0%)
USD 39.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -87.41 Million | -97.28 Million | -130.63 Million | -67.51 Million | -82.57 Million | -33.22 Million |
| Net Income | -117.56 Million | -171.11 Million | -225.73 Million | -135.64 Million | -52.37 Million | -39.1 Million |
| Depreciation & Amortization | 43.43 Million | 62.63 Million | 51.14 Million | 39.25 Million | 31.86 Million | 18.86 Million |
| Deferred income taxes | -1.08 Million | -694 Thousand | -1.67 Million | 687 Thousand | 987 Thousand | 188 Thousand |
| Stock-based compensation | 3.93 Million | 3.7 Million | 8.56 Million | 17.14 Million | 3.87 Million | 1.98 Million |
| Change in working capital | -34.14 Million | 10.87 Million | 17.75 Million | 6.27 Million | -26.8 Million | -20.17 Million |
| Other non-cash items | 20.85 Million | 326 Thousand | 26.2 Million | 22.6 Million | -35.24 Million | 7.18 Million |
| Investing Cash Flow | 219.81 Million | -89.77 Million | -67.32 Million | -199.85 Million | -143.18 Million | -140.27 Million |
| Investments in PPE | -27.7 Million | -59.28 Million | -63.47 Million | -59.82 Million | -41.51 Million | -31.5 Million |
| Acquisitions | 268.85 Million | -596 Thousand | -2.59 Million | -116.04 Million | -103.07 Million | -108.56 Million |
| Investment purchases | -51.04 Million | -34.14 Million | -2.49 Million | -24 Million | -3.21 Million | -450 Thousand |
| Sales/Maturities of investments | 37.72 Million | 3.68 Million | 1.23 Million | 25 Thousand | 49 Thousand | 244 Thousand |
| Other Investing Activities | -8 Million | 573 Thousand | -56.85 Million | -57.39 Million | 4.56 Million | -21.45 Million |
| Financing Cash Flow | -202.62 Million | 39.1 Million | 179.72 Million | 363.24 Million | 200.19 Million | 297.05 Million |
| Debt repayment | -202.29 Million | -506 Thousand | -7.58 Million | -157.89 Million | -204.91 Million | -1.79 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -4000.00 | -2000.00 | -1000.00 | -6.36 Million |
| Common Stock Issuance | 31 Thousand | 42.05 Million | 187.3 Million | 206.09 Million | 496 Thousand | 191.14 Million |
| Other Financing Activities | -202.65 Million | -2.44 Million | 7.58 Million | 472.94 Million | 609.51 Million | 115.85 Million |
| Accounts receivables | -4.54 Million | 8.89 Million | -29.04 Million | 13.51 Million | -37.26 Million | -12.23 Million |
| Accounts payables | -19.49 Million | -10.7 Million | 52.27 Million | 8.87 Million | 13.48 Million | 4.12 Million |
| Inventory | -4.26 Million | 6.85 Million | -3.03 Million | -20.06 Million | -3.39 Million | -10.27 Million |
| Other working capital | -5.84 Million | 5.82 Million | -2.44 Million | 3.95 Million | 369 Thousand | -9.89 Million |
| Cash at beginning of period | 126.04 Million | 277.74 Million | 300.61 Million | 204.68 Million | 230.69 Million | 107.76 Million |
| Cash at end of period | 54.02 Million | 126.04 Million | 277.74 Million | 300.61 Million | 204.68 Million | 230.69 Million |
| Capital Expenditure | -27.7 Million | -59.28 Million | -63.47 Million | -59.82 Million | -41.51 Million | -31.5 Million |
| Effect of forex changes on cash | -1.79 Million | -3.74 Million | -4.63 Million | 53 Thousand | -450 Thousand | -624 Thousand |
| Net cash flow / Change in cash | -72.01 Million | -151.7 Million | -22.87 Million | 95.93 Million | -26.01 Million | 122.92 Million |
| Free Cash Flow | -115.12 Million | -156.57 Million | -194.1 Million | -127.33 Million | -124.08 Million | -64.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.96 Million | -18.96 Million | -59.32 Million | -117.56 Million | -29.66 Million | -58.24 Million |
| Depreciation & Amortization | 11.37 Million | 11.37 Million | 24.18 Million | 43.43 Million | 301.5 Thousand | 20.67 Million |
| Deferred income taxes | - | - | -1.08 Million | -1.08 Million | - | - |
| Stock-based compensation | - | - | 1.96 Million | 3.93 Million | 1.96 Million | - |
| Change in working capital | 4.34 Million | 4.34 Million | -31.33 Million | -34.14 Million | -14.46 Million | -6.8 Million |
| Other non-cash items | -2.61 Million | -2.61 Million | 92.3 Million | 20.85 Million | 16.27 Million | 50.37 Million |
| Investing Cash Flow | -3.37 Million | -3.37 Million | -38.84 Million | 219.81 Million | -19.42 Million | 258.52 Million |
| Investments in PPE | -270.5 Thousand | -270.5 Thousand | -18.77 Million | -27.7 Million | -1.82 Million | -8.93 Million |
| Acquisitions | 47.04 Million | - | -6.99 Million | 268.85 Million | - | 275.98 Million |
| Investment purchases | -60.27 Million | - | -50.74 Million | -51.04 Million | - | -300 Thousand |
| Sales/Maturities of investments | 20 Million | - | 37.69 Million | 37.72 Million | - | 32 Thousand |
| Other Investing Activities | -3.09 Million | -3.09 Million | -24 Thousand | -8 Million | -17.59 Million | -8.26 Million |
| Financing Cash Flow | 34.29 Million | 34.29 Million | -54 Million | -202.62 Million | -27 Million | -148.62 Million |
| Debt repayment | -68.53 Million | - | -53.94 Million | -202.29 Million | - | -148.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -32 Thousand | - | -32 Thousand | - |
| Common Stock Issuance | 63 Thousand | - | -64 Thousand | 31 Thousand | - | 95 Thousand |
| Other Financing Activities | 34.29 Million | 34.29 Million | -26.97 Million | -202.65 Million | -26.97 Million | -368 Thousand |
| Accounts receivables | -40.5 Thousand | -40.5 Thousand | -14.34 Million | -4.54 Million | -7.17 Million | 9.79 Million |
| Accounts payables | 7.88 Million | - | -2.39 Million | -19.49 Million | - | -17.09 Million |
| Inventory | 4.68 Million | 4.68 Million | -10.81 Million | -4.26 Million | -5.4 Million | 6.55 Million |
| Other working capital | -303.5 Thousand | -303.5 Thousand | -3.77 Million | -5.84 Million | -1.88 Million | -6.05 Million |
| Cash at beginning of period | 54.02 Million | - | 199.71 Million | 126.04 Million | - | 126.04 Million |
| Cash at end of period | 105.11 Million | 25.54 Million | 54.02 Million | 54.02 Million | -72.84 Million | 199.71 Million |
| Capital Expenditure | -270.5 Thousand | -270.5 Thousand | -18.77 Million | -27.7 Million | -1.82 Million | -8.93 Million |
| Effect of forex changes on cash | 482 Thousand | 482 Thousand | -824.5 Thousand | -1.79 Million | -824.5 Thousand | -71 Thousand |
| Net cash flow / Change in cash | 51.08 Million | 25.54 Million | -145.68 Million | -72.01 Million | -72.84 Million | 73.67 Million |
| Free Cash Flow | -6.13 Million | -6.13 Million | -69.96 Million | -115.12 Million | -27.42 Million | -45.02 Million |
BCU
LADDERUP
1718
BKT
BIO
BENGALASM